EFFECTS OF BETA-1-BLOCKADE AND BETA-2-BLOCKADE ON BLOOD-PRESSURE AND SYMPATHETIC RESPONSES TO FLIGHT PHOBIA STRESS

被引:9
作者
EKEBERG, O
KJELDSEN, SE
EIDE, IK
GREENWOOD, DT
ENGER, E
机构
[1] ULLEVAL UNIV HOSP, DEPT INTERNAL MED, N-0407 OSLO 4, NORWAY
[2] ICI PHARMACEUT PLC, MED RES DEPT, CHESHIRE, ENGLAND
关键词
D O I
10.1038/clpt.1990.81
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiovascular and sympathoadrenal effects of short‐term oral treatment with β1‐blockade (atenolol, 50 mg, administered two times) and β2‐blockade (ICI 118,551, 50 mg, administered three times) were compared with placebo during actual flying in subjects with flight phobia (n = 34). β1‐Blockade lowered resting blood pressure and heart rate and prevented a heart rate response but not a blood pressure response to this psychologic stress. β2‐Blockade minimally lowered resting heart rate and prevented a heart rate response, but it failed to lower resting blood pressure or blood pressure response to the stress. Plasma epinephrine increased with all three treatments and more with β1‐blockade than with placebo. Plasma norepinephrine decreased with administration of β2‐blockade. Thus neither β1‐ nor β2‐blockade prevents an increase in blood pressure during acute flight phobia stress. Increased plasma epinephrine seems to be the sympathetic variable that is closest related to this increase in blood pressure. Norepinephrine may be less consistently related to the blood pressure rise during flight phobia stress as shown by the decrease in plasma norepinephrine with administration of β2‐blockade. Clinical Pharmacology and Therapeutics (1990) 47, 599–607; doi: © 1990 American Society for Clinical Pharmacology and Therapeutics
引用
收藏
页码:599 / 607
页数:9
相关论文
共 59 条
[1]   POSSIBLE ROLE OF A BETA-ADRENOCEPTOR IN REGULATION OF NORADRENALINE RELEASE BY NERVE-STIMULATION THROUGH A POSITIVE FEEDBACK MECHANISM [J].
ADLERGRASCHINSK.E ;
LANGER, SZ .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (01) :43-50
[2]   EPIDEMIOLOGY OF COMMON FEARS AND PHOBIA [J].
AGRAS, S ;
SYLVESTER, D ;
OLIVEAU, D .
COMPREHENSIVE PSYCHIATRY, 1969, 10 (02) :151-+
[3]   DISSOCIATION OF SYMPATHETIC-NERVE ACTIVITY IN ARM AND LEG MUSCLE DURING MENTAL STRESS [J].
ANDERSON, EA ;
WALLIN, BG ;
MARK, AL .
HYPERTENSION, 1987, 9 (06) :114-119
[4]  
ANDREN L, 1980, ACTA MED SCAND, V646, P69
[5]   PHYSIOLOGICAL AND PHARMACOLOGICAL ASPECTS OF ADRENERGIC-RECEPTOR CLASSIFICATION [J].
ARIENS, EJ ;
SIMONIS, AM .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (10) :1539-1545
[6]   RELEASE AND CLEARANCE RATES OF EPINEPHRINE IN MAN - IMPORTANCE OF ARTERIAL MEASUREMENTS [J].
BEST, JD ;
HALTER, JB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (02) :263-268
[7]   THE PHARMACOLOGY OF A BETA-2-SELECTIVE ADRENOCEPTOR ANTAGONIST (ICI-118,551) [J].
BILSKI, AJ ;
HALLIDAY, SE ;
FITZ GERALD, JD ;
WALE, JL .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (03) :430-437
[8]   ADRENALINE AND ENHANCED VASOCONSTRICTION IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].
BOLLI, P ;
KIOWSKI, W ;
AMANN, FW ;
BUHLER, FR .
PHARMACOLOGY & TOXICOLOGY, 1988, 63 :41-44
[9]   EFFECT OF CALCULATION STRESS ON HEMODYNAMICS AND PLASMA CATECHOLAMINES BEFORE AND AFTER BETA-BLOCKADE WITH PROPRANOLOL (INDERAL) AND MEPINDOLOL SULFATE (CORINDOLAN) [J].
BONELLI, J ;
HORTNAGL, H ;
BRUCKE, T ;
MAGOMETSCHNIGG, D ;
LOCHS, H ;
KAIK, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (01) :1-8
[10]  
BROD J, 1963, BRIT HEART J, V25, P227